All treatments
Treatment
Vocabria 30 mg film-coated tablets clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
Implementation of Out-of-HOspital administration of the Long-Acting combination cabotegravir+rilpivirine as an optional therapy in HIV-Infected patients from Spain. Acceptability, appropriateness, feasibility and satisfaction. The HOLA Study.
This study looks at a new way to give HIV treatment using long-acting injections instead of daily pills. It wants to see how well patients like it, if it's easy to use, and if it's safe outside of the hospital.
For: HIV-Infected patientsSpain - Ongoing, recruitingTherapeutic confirmatory (Phase III)
(CAbotégravir LENacapavir DUal Long Acting). Phase II, Pilot study, open label, multicenter, evaluating dual antiretroviral therapy with long-acting cabotegravir/lenacapavir IMEA 069 - CALENDULA
This study is looking at two long-acting HIV medicines given together to see how well they control the virus. It's for adults living with HIV and aims to find out if this combination is effective and safe over 48 weeks.
For: HIV infectionFrance